Literature DB >> 11522015

Fibrinolysis/proteolysis balance in stable angina pectoris in relation to angiographic findings.

J A Páramo1, J Orbe, J Fernández.   

Abstract

The plasma fibrinolytic/proteolytic balance was assessed in 60 stable angina patients who underwent control coronary catheterization and the results were correlated with angiographic findings and control samples (n = 20). The concentrations of t-PA, PAI-1, collagenase (MMP-1), tissue inhibitor of MMP (TIMP-1), plasmin-antiplasmin (PAP) complexes and alpha2-macroglobulin (alpha2-M) were measured in plasma samples. The results showed a significant increase of PAP (p <0.001) and a reduction of alpha2-M (p <0.001) in the group of patients when compared to controls, indicating a degree of fibrinolysis/proteolysis activation. There was no correlation between the different parameters analyzed and the extent of angiographically proven atherosclerosis (one or more stenotic vessels), while the t-PA levels were significantly elevated (p <0.03) in patients with coronary stenosis > or =75% or occlusion. We conclude that there is a disturbance of the plasma fibrinolysis/proteolysis in patients with stable angina not related to the extent of atherosclerosis. The t-PA levels may be a good marker for coronary occlusion in these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522015

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  2 in total

1.  Is aprotinin safe to use in a cohort at increased risk for thrombotic events: results from a randomized, prospective trial in off-pump coronary artery bypass.

Authors:  Michael C Grant; Zachary Kon; Ashish Joshi; Eric Christenson; Seeta Kallam; Nicholas Burris; Junyan Gu; Robert S Poston
Journal:  Ann Thorac Surg       Date:  2008-09       Impact factor: 4.330

Review 2.  Dry eye: an inflammatory ocular disease.

Authors:  Michelle Hessen; Esen Karamursel Akpek
Journal:  J Ophthalmic Vis Res       Date:  2014-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.